{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:15:54Z","timestamp":1770041754125,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.rmed.2020.105936","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T13:59:04Z","timestamp":1584367144000},"page":"105936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis"],"prefix":"10.1016","volume":"165","author":[{"given":"Roeland","family":"Vis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewoudt M.W.","family":"van de Garde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Meek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid H.E.","family":"Korenromp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2020.105936_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2020.105936_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00337-10","article-title":"Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis","volume":"18","author":"Loza","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.rmed.2020.105936_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.06.00105805","article-title":"Corticosteroid treatment in sarcoidosis","volume":"28","author":"Grutters","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105936_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-2977(98)00058-8","article-title":"Clinical presentation of sarcoidosis in The Netherlands an epidemiological study","volume":"53","author":"Wirnsberger","year":"1998","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.rmed.2020.105936_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0954-6111(98)90007-5","article-title":"Evaluation of quality of life in sarcoidosis patients","volume":"92","author":"Wirnsberger","year":"1998","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.105936_bib6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.105936_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1378\/chest.10-2629","article-title":"Characterization of chronic fatigue in patients with sarcoidosis in clinical remission","volume":"140","author":"Korenromp","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.105936_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1752-699X.2010.00214.x","article-title":"Fatigue and plasma cytokine concentrations at rest and during exercise in patients with sarcoidosis","volume":"5","author":"Baydur","year":"2011","journal-title":"Clin. Res. J."},{"key":"10.1016\/j.rmed.2020.105936_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"Drent","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105936_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet. Respir. Med."},{"key":"10.1016\/j.rmed.2020.105936_bib11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105936_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(67)90493-X","article-title":"Treatment of sarcoidosis. Report of a controlled therapeutic trial","volume":"2","author":"James","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2020.105936_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/arrd.1973.107.4.609","article-title":"A controlled trial of prednisone treatment of sarcoidosis","volume":"107","author":"Israel","year":"1973","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2020.105936_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccm.2015.08.014","article-title":"Quality of life assessment in sarcoidosis","volume":"36","author":"Judson","year":"2015","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.rmed.2020.105936_bib15","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2020.105936_bib16","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1378\/chest.116.5.1175","article-title":"Assessment of health-related quality of life in patients with interstitial lung disease","volume":"116","author":"Chang","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.105936_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thx.2004.022244","article-title":"Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status","volume":"60","author":"Spruit","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2020.105936_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-244X-6-34","article-title":"The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization","volume":"6","author":"Terluin","year":"2006","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.rmed.2020.105936_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.rmed.2020.105936_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1037\/1076-8998.5.4.411","article-title":"Measurement of prolonged fatigue at work in the maastricht cohort study: determination of a cutoff point for the checklist individual strength","volume":"5","author":"Bultmann","year":"2000","journal-title":"J. Occup. Health Psychol."},{"key":"10.1016\/j.rmed.2020.105936_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-016-0167-6","article-title":"Minimal important differences for fatigue patient reported outcome measures - a systematic review","volume":"16","author":"Nordin","year":"2016","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.rmed.2020.105936_bib22","first-page":"117","article-title":"Association between physical functions and quality of life in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis, Vasc. Diffus. Lung Dis. Off. J. WASOG."},{"key":"10.1016\/j.rmed.2020.105936_bib23","series-title":"Sarcoidosis and Other Granulomatous ILD\/DPLD","first-page":"PA5219","article-title":"Sarcoidosis treatment and outcomes: what is most important to patients?","author":"Boyd","year":"2018"},{"key":"10.1016\/j.rmed.2020.105936_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1183\/09031936.99.14511179","article-title":"Treatment of chronic sarcoidosis with an azathioprine\/prednisolone regimen","volume":"14","author":"M\u00fcller-Quernheim","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105936_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.105936_bib26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1378\/chest.124.4.1526","article-title":"Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone","volume":"124","author":"Tong","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.105936_bib27","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.159.9.4593","article-title":"Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation","volume":"159","author":"Lamkhioued","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.rmed.2020.105936_bib28","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3producing t-helper 17.1 cells are increased in sarcoidosis and are more prevalent than t-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2020.105936_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1183\/13993003.00092-2016","article-title":"Expanded lung T-bet+ROR\u03b3T+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype","volume":"48","author":"Kaiser","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105936_bib30","first-page":"57","article-title":"Relationship between perceived stress and sarcoidosis in a Dutch patient population","volume":"21","author":"De Vries","year":"2004","journal-title":"Sarcoidosis, Vasc. Diffus. Lung Dis. Off. J. WASOG."},{"key":"10.1016\/j.rmed.2020.105936_bib31","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1183\/09031936.00117710","article-title":"Exercise capacity, muscle strength and fatigue in sarcoidosis","volume":"38","author":"Marcellis","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105936_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1440-1843.2012.02134.x","article-title":"Validation of the sarcoidosis health questionnaire in a non-US population","volume":"17","author":"De Boer","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2020.105936_bib33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.105936_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/5584_2014_18","article-title":"Fatigue in sarcoidosis and exercise tolerance, dyspnea, and quality of life","volume":"833","author":"Jastrz\u0119bski","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.rmed.2020.105936_bib35","first-page":"124","article-title":"Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids","volume":"33","author":"Aggarwal","year":"2016","journal-title":"Sarcoidosis, Vasc. Diffus. Lung Dis. Off. J. WASOG."},{"key":"10.1016\/j.rmed.2020.105936_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","article-title":"Repository corticotropin for chronic pulmonary sarcoidosis","volume":"195","author":"Baughman","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2020.105936_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2019","article-title":"The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review","volume":"29","author":"Vis","year":"2020","journal-title":"Eur. Respir. Rev."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120300767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:57:56Z","timestamp":1760615876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120300767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":37,"alternative-id":["S0954611120300767"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105936","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105936"}}